The outbreak of invasive fungal infections among patients who received injections of contaminated methylprednisolone acetate prepared by the New England Compounding Center (in Framingham, Massachusetts) is a disturbing tragedy, already the largest health care–associated fungal outbreak reported in the United States, with 693 cases and 45 deaths reported as of January 28, 2013.1 Effectively responding to this catastrophic event required rapid actions by clinical and public health practitioners who worked to ensure discontinued use of the suspect medication, notify at-risk patients and their physicians, and decipher the many unknowns about the outbreak to provide the best guidance for minimizing harm.
Each 30-day case-fatality rate is calculated for patients diagnosed during the corresponding week. TDOH indicates Tennessee Department of Health; NECC, New England Compounding Center; CDC, Centers for Disease Control and Prevention; FDA, US Food and Drug Administration.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.